Drug Pipeline

PLB1004 Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
1
Recruiting
1
Phase 3
1
Top Sponsors
Active Studies by Phase
Phase 3
1
Phase 2
2
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT06281964 Efficacy and Safety Evaluation of PLB1004 in Patients With Non-squamous NSCLC Harboring… Non-Small-Cell Lung Cancer Enrolling by Invitation
Phase 2
NCT07336732 Andamertinib With or Without Platinum-doublet Chemotherapy Versus Platinum-doublet… Non-Small-Cell Lung Cancer Recruiting
NCT06015503 A Phase Ⅱ Study Assessing the Safety and Efficacy of PLB1004 in EGFR ex20ins Mutation… NSCLC (Non-small Cell Lung Cancer) Active, Not Recruiting
Sponsors Running PLB1004 Trials
Disease Areas
Get alerts when PLB1004 trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free